A July 2025 JAMA review highlights that PFO closure has shifted from a broad intervention to a more targeted therapy, with careful patient selection—guided by two key tools—at the heart of decision-making

As we think about the educational and scientific content we share on VLN, the intersection of VTE with metabolic disorders has come up repeatedly in our discussions. How and why would metabolic disorders influence thrombosis?

Alfonso J Tafur interviews McMaster University’s Dr. Alexander Godoy and Medical Student Tegvir Singh Grewal at ISTH 2025

This In Focus feature in Lancet Haematology highlights the creation of a global clinician toolkit designed to enhance clear, compassionate communication throughout the VTE diagnostic journey and beyond.

This presentation explores the persistent challenges in managing atrial fibrillation (AF) — particularly the limitations of current oral anticoagulants. While therapies like warfarin and DOACs have been transformative, concerns about bleeding, dosing complexity, and adherence continue to impact real-world effectiveness.

Heart failure (HF) is a serious condition that affects millions of people worldwide and is becoming more common as the population ages. Most people know that it causes fatigue, swelling, and shortness of breath.

VLN is proud to present our latest Action Initiative, “Assessing and Addressing the Risk of Venous Thromboembolism (VTE) Across the Spectrum of Gender-Affirming Care,” published in Endocrine Practice.

VLN is proud to present this collection of review articles on cancer-associated thrombosis (CAT), published online in The Oncologist. The series concludes with a comprehensive review of cancer-specific guidelines and outlines areas where additional guidance is warranted.

The VLN Atrial Fibrillation Action Initiative identifies multidisciplinary best practices for stroke prevention in atrial fibrillation (Afib). Our mission is to provide a comprehensive yet concise consensus document focused on stroke and bleeding risk assessment in patients with Afib as well as anticoagulation options and management.

Hospitalized patients with acute medical illnesses are at significant risk for venous thromboembolism (VTE) during and after a hospital stay. Strategies for optimal pharmacologic VTE thromboprophylaxis are evolving but necessary to protect high-risk patients after hospital discharge.

Mindfulness is a simple meditation technique that promotes present-moment awareness, helping individuals stay focused and engaged in their daily activities. Recent studies suggest that mindfulness can enhance patient care, prevent physician burnout, and improve job satisfaction in the medical field.

Recent studies suggest that even for "provoked" DVT or PE, some patients have persistent risk factors that significantly increase their risk of recurrence. These patients may benefit from long-term anticoagulation, even though traditional guidelines recommend stopping treatment.